Insmed - 24 Year Stock Price History | INSM

Historical daily share price chart and data for Insmed since 2000 adjusted for splits and dividends. The latest closing stock price for Insmed as of April 26, 2024 is 24.80.
  • The all-time high Insmed stock closing price was 195.00 on August 30, 2000.
  • The Insmed 52-week high stock price is 32.00, which is 29% above the current share price.
  • The Insmed 52-week low stock price is 18.09, which is 27.1% below the current share price.
  • The average Insmed stock price for the last 52 weeks is 24.60.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Insmed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 27.6088 29.9400 29.9400 24.1100 24.8000 -19.97%
2023 21.8217 19.1800 31.7400 16.2600 30.9900 55.11%
2022 21.8800 28.1300 28.2100 16.9800 19.9800 -26.65%
2021 30.5951 33.4200 44.3000 22.4600 27.2400 -18.17%
2020 28.2231 23.6600 40.5400 13.6300 33.2900 39.41%
2019 23.3077 13.9700 32.1900 13.9100 23.8800 82.01%
2018 22.6387 32.4600 32.9900 11.6000 13.1200 -57.92%
2017 20.2914 13.0800 31.7800 11.6100 31.1800 135.68%
2016 12.7351 17.2400 17.2400 9.0500 13.2300 -27.11%
2015 20.7534 15.9600 27.5400 14.1600 18.1500 17.32%
2014 15.7364 17.1400 21.5400 11.6500 15.4700 -9.00%
2013 11.2478 6.9600 17.3300 5.7200 17.0000 154.11%
2012 4.3827 3.1500 8.0000 2.7000 6.6900 119.34%
2011 6.4065 6.4000 13.1500 2.6400 3.0500 -51.65%
2010 8.1390 7.7000 12.5000 5.7000 6.3080 -18.08%
2009 9.7689 4.9000 24.7000 4.1500 7.7000 64.71%
2008 6.0865 8.3000 9.1000 3.4990 4.6750 -43.33%
2007 8.8034 9.0000 15.6000 5.7700 8.2500 -6.25%
2006 16.1210 21.3000 31.2000 8.5000 8.8000 -55.33%
2005 12.6992 23.0000 23.0000 8.2000 19.7000 -10.41%
2004 23.1546 30.3000 40.9000 10.1000 21.9900 -25.96%
2003 20.0198 4.8000 34.2000 4.1000 29.7000 561.47%
2002 17.7447 39.4000 39.4000 3.5000 4.4900 -88.25%
2001 45.0069 37.5000 89.9000 24.7000 38.2000 10.12%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.702B $0.305B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.489B 14.44
Vertex Pharmaceuticals (VRTX) United States $102.789B 29.59
Regeneron Pharmaceuticals (REGN) United States $97.763B 23.70
Bristol Myers Squibb (BMY) United States $90.596B 6.08
CSL (CSLLY) Australia $87.140B 0.00
GSK (GSK) United Kingdom $84.784B 10.63
Gilead Sciences (GILD) United States $81.266B 16.20
Moderna (MRNA) United States $40.654B 0.00
Biogen (BIIB) United States $29.478B 13.50
Argenex SE (ARGX) Netherlands $21.906B 0.00
BioNTech SE (BNTX) Germany $20.613B 21.05
Illumina (ILMN) United States $19.278B 139.14
Genmab (GMAB) Denmark $18.157B 23.27
Alnylam Pharmaceuticals (ALNY) United States $18.100B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.508B 60.87
BeiGene (BGNE) Cayman Islands $14.208B 0.00
Sarepta Therapeutics (SRPT) United States $12.039B 0.00
Incyte (INCY) United States $11.491B 19.10
Exact Sciences (EXAS) United States $10.672B 0.00
Bio-Techne Corp (TECH) United States $9.850B 36.64
QIAGEN (QGEN) Netherlands $9.375B 19.41
Repligen (RGEN) United States $9.250B 95.76
Roivant Sciences (ROIV) United Kingdom $8.768B 0.00
Legend Biotech (LEGN) United States $8.080B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Ascendis Pharma (ASND) Denmark $7.973B 0.00
Viking Therapeutics (VKTX) United States $7.590B 0.00
Intra-Cellular Therapies (ITCI) United States $6.983B 0.00
Exelixis (EXEL) United States $6.937B 36.77
Cytokinetics (CYTK) United States $6.777B 0.00
Vaxcyte (PCVX) United States $6.532B 0.00
Apellis Pharmaceuticals (APLS) United States $5.779B 0.00
Blueprint Medicines (BPMC) United States $5.553B 0.00
Halozyme Therapeutics (HALO) United States $4.887B 15.08
CRISPR Therapeutics AG (CRSP) Switzerland $4.561B 0.00
Krystal Biotech (KRYS) United States $4.439B 0.00
Zealand Pharma (ZLDPF) Denmark $4.439B 0.00
Nuvalent (NUVL) United States $4.233B 0.00
Alkermes (ALKS) Ireland $4.135B 21.82
Immunovant (IMVT) United States $4.032B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.609B 0.00
ImmunityBio (IBRX) United States $3.459B 0.00
Biohaven (BHVN) United States $3.401B 0.00
Axsome Therapeutics (AXSM) United States $3.388B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.309B 0.00
SpringWorks Therapeutics (SWTX) United States $3.261B 0.00
Fortrea Holdings (FTRE) United States $3.249B 0.00
Iovance Biotherapeutics (IOVA) United States $3.223B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.025B 0.00
Amicus Therapeutics (FOLD) United States $3.012B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.890B 0.00
IDEAYA Biosciences (IDYA) United States $2.887B 0.00
Arcellx (ACLX) United States $2.738B 0.00
MorphoSys AG (MOR) Germany $2.731B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.699B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.687B 0.00
Merus (MRUS) Netherlands $2.637B 0.00
Certara (CERT) United States $2.611B 56.21
Janux Therapeutics (JANX) United States $2.433B 0.00
CG Oncology (CGON) United States $2.412B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.294B 0.00
Vericel (VCEL) United States $2.199B 0.00
Arvinas (ARVN) United States $2.159B 0.00
Denali Therapeutics (DNLI) United States $2.132B 0.00
Vera Therapeutics (VERA) United States $2.107B 0.00
Guardant Health (GH) United States $2.089B 0.00
Kymera Therapeutics (KYMR) United States $2.046B 0.00
Celldex Therapeutics (CLDX) United States $2.027B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.000B 0.00
Apogee Therapeutics (APGE) United States $1.968B 0.00
Keros Therapeutics (KROS) United States $1.955B 0.00
Geron (GERN) United States $1.947B 0.00
Intellia Therapeutics (NTLA) United States $1.931B 0.00
Avidity Biosciences (RNA) United States $1.900B 0.00
Galapagos (GLPG) Belgium $1.887B 0.00
Sana Biotechnology (SANA) United States $1.874B 0.00
Structure Therapeutics (GPCR) United States $1.816B 0.00
Twist Bioscience (TWST) United States $1.797B 0.00
Beam Therapeutics (BEAM) United States $1.778B 0.00
NeoGenomics (NEO) United States $1.768B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.748B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.674B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.643B 13.65
Myriad Genetics (MYGN) United States $1.627B 0.00
Bavarian Nordic (BVNRY) Denmark $1.621B 5.32
Inhibrx (INBX) United States $1.616B 0.00
Zai Lab (ZLAB) China $1.562B 0.00
Edgewise Therapeutics (EWTX) United States $1.484B 0.00
ADMA Biologics Inc (ADMA) United States $1.470B 0.00
Dynavax Technologies (DVAX) United States $1.462B 0.00
Kura Oncology (KURA) United States $1.447B 0.00
Neumora Therapeutics (NMRA) United States $1.440B 0.00
Protagonist Therapeutics (PTGX) United States $1.437B 0.00
Morphic Holding (MORF) United States $1.400B 0.00
Gyre Therapeutics (GYRE) United States $1.395B 0.00
ANI Pharmaceuticals (ANIP) United States $1.369B 16.83
Arcus Biosciences (RCUS) United States $1.340B 0.00
Akero Therapeutics (AKRO) United States $1.309B 0.00
Ligand Pharmaceuticals (LGND) United States $1.246B 15.43
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.244B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.237B 0.00
Spyre Therapeutics (SYRE) United States $1.174B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.154B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.154B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.146B 0.00
MannKind (MNKD) United States $1.131B 0.00
Belite Bio (BLTE) United States $1.108B 0.00
Prothena (PRTA) Ireland $1.104B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.102B 0.00
Scholar Rock Holding (SRRK) United States $1.087B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.085B 0.00
AbCellera Biologics (ABCL) Canada $1.063B 0.00
Vir Biotechnology (VIR) United States $1.026B 0.00
Abivax SA (ABVX) France $0.991B 0.00
Liquidia Technologies (LQDA) United States $0.940B 0.00
MiMedx (MDXG) United States $0.922B 208.17
Immunome (IMNM) United States $0.851B 0.00
ALX Oncology Holdings (ALXO) United States $0.844B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.832B 0.00
Cullinan Therapeutics (CGEM) United States $0.829B 0.00
Immatics (IMTX) Germany $0.828B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.805B 0.00
Viridian Therapeutics (VRDN) United States $0.797B 0.00
Tyra Biosciences (TYRA) United States $0.794B 0.00
REGENXBIO (RGNX) United States $0.788B 0.00
89BIO (ETNB) United States $0.786B 0.00
Tango Therapeutics (TNGX) United States $0.782B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.780B 0.00
PureTech Health (PRTC) United States $0.742B 0.00
Cytek Biosciences (CTKB) United States $0.737B 0.00
CARGO Therapeutics (CRGX) United States $0.720B 0.00
Pliant Therapeutics (PLRX) United States $0.717B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.704B 0.00
Mesoblast (MESO) Australia $0.702B 0.00
Pharming Group (PHAR) Netherlands $0.701B 0.00
Praxis Precision Medicines (PRAX) United States $0.700B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.693B 0.00
Kyverna Therapeutics (KYTX) United States $0.687B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.677B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.650B 0.00
EnGene Holdings (ENGN) United States $0.642B 0.00
Disc Medicine (IRON) United States $0.640B 0.00
Dianthus Therapeutics (DNTH) United States $0.616B 0.00
Stoke Therapeutics (STOK) United States $0.609B 0.00
Nurix Therapeutics (NRIX) United States $0.608B 0.00
Aerovate Therapeutics (AVTE) United States $0.601B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.599B 0.00
HilleVax (HLVX) United States $0.598B 0.00
Pharming Group (PHGUF) Netherlands $0.591B 0.00
WAVE Life Sciences (WVE) Singapore $0.580B 0.00
Cogent Biosciences (COGT) United States $0.575B 0.00
Northwest Biotherapeutics (NWBO) United States $0.574B 0.00
Zymeworks (ZYME) United States $0.572B 0.00
Nuvation Bio (NUVB) United States $0.571B 0.00
Cabaletta Bio (CABA) United States $0.570B 0.00
Novavax (NVAX) United States $0.553B 0.00
Olema Pharmaceuticals (OLMA) United States $0.550B 0.00
Mineralys Therapeutics (MLYS) United States $0.548B 0.00
GH Research (GHRS) Ireland $0.546B 0.00
Castle Biosciences (CSTL) United States $0.536B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
ArriVent BioPharma (AVBP) United States $0.520B 0.00
CureVac (CVAC) Germany $0.517B 0.00
Oric Pharmaceuticals (ORIC) United States $0.517B 0.00
Prime Medicine (PRME) United States $0.516B 0.00
AnaptysBio (ANAB) United States $0.516B 0.00
Absci (ABSI) United States $0.504B 0.00
Astria Therapeutics (ATXS) United States $0.504B 0.00
Adlai Nortye (ANL) Cayman Islands $0.497B 0.00
Arbutus Biopharma (ABUS) United States $0.488B 0.00
Allogene Therapeutics (ALLO) United States $0.487B 0.00
Oculis Holding AG (OCS) Switzerland $0.484B 0.00
Applied Therapeutics (APLT) United States $0.483B 0.00
Celcuity (CELC) United States $0.480B 0.00
Shattuck Labs (STTK) United States $0.465B 0.00
Avid Bioservices (CDMO) United States $0.465B 0.00
Humacyte (HUMA) United States $0.464B 0.00
Alector (ALEC) United States $0.461B 0.00
IGM Biosciences (IGMS) United States $0.450B 0.00
Fulcrum Therapeutics (FULC) United States $0.443B 0.00
Fate Therapeutics (FATE) United States $0.440B 0.00
Editas Medicine (EDIT) United States $0.429B 0.00
C4 Therapeutics (CCCC) United States $0.428B 0.00
Third Harmonic Bio (THRD) United States $0.426B 0.00
ACELYRIN, INC (SLRN) United States $0.419B 0.00
Entrada Therapeutics (TRDA) United States $0.415B 0.00
Annexon (ANNX) United States $0.413B 0.00
Travere Therapeutics (TVTX) United States $0.410B 0.00
Voyager Therapeutics (VYGR) United States $0.403B 2.40
MaxCyte (MXCT) United States $0.385B 0.00
Neurogene (NGNE) United States $0.384B 0.00
FibroBiologics (FBLG) United States $0.381B 0.00
ITeos Therapeutics (ITOS) United States $0.380B 0.00
Alto Neuroscience (ANRO) United States $0.380B 0.00
Anika Therapeutics (ANIK) United States $0.380B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.379B 0.00
Adaptive Biotechnologies (ADPT) United States $0.379B 0.00
PepGen (PEPG) United States $0.379B 0.00
Replimune (REPL) United States $0.378B 0.00
Biomea Fusion (BMEA) United States $0.376B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.368B 0.00
Amarin (AMRN) Ireland $0.353B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.351B 0.00
Aura Biosciences (AURA) United States $0.350B 0.00
TScan Therapeutics (TCRX) United States $0.349B 0.00
Precigen (PGEN) United States $0.348B 0.00
Mersana Therapeutics (MRSN) United States $0.346B 0.00
Revance Therapeutics (RVNC) United States $0.343B 0.00
Caribou Biosciences (CRBU) United States $0.340B 0.00
Nkarta (NKTX) United States $0.337B 0.00
Tenaya Therapeutics (TNYA) United States $0.331B 0.00
Rani Therapeutics Holdings (RANI) United States $0.329B 0.00
Urogen Pharma (URGN) United States $0.324B 0.00
Solid Biosciences (SLDB) United States $0.323B 0.00
Jasper Therapeutics (JSPR) United States $0.319B 0.00
Atea Pharmaceuticals (AVIR) United States $0.311B 0.00
Ocugen (OCGN) United States $0.304B 0.00
MeiraGTx Holdings (MGTX) United States $0.302B 0.00
Terns Pharmaceuticals (TERN) United States $0.300B 0.00
Kamada (KMDA) Israel $0.299B 22.61
Nautilus Biotechnology (NAUT) United States $0.295B 0.00
XOMA (XOMA) United States $0.295B 0.00
Contineum Therapeutics (CTNM) United States $0.292B 0.00
Ventyx Biosciences (VTYX) United States $0.286B 0.00
Erasca (ERAS) United States $0.285B 0.00
CorMedix Inc (CRMD) United States $0.284B 0.00
Anavex Life Sciences (AVXL) United States $0.278B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.273B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.271B 0.00
Rapt Therapeutics (RAPT) United States $0.271B 0.00
Werewolf Therapeutics (HOWL) United States $0.269B 0.00
Inozyme Pharma (INZY) United States $0.267B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.262B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.258B 89.60
ChromaDex (CDXC) United States $0.255B 0.00
XBiotech (XBIT) United States $0.250B 0.00
Invivyd (IVVD) United States $0.247B 0.00
Renovaro (RENB) United States $0.244B 0.00
Inovio Pharmaceuticals (INO) United States $0.237B 0.00
Puma Biotechnology (PBYI) United States $0.235B 10.61
Verastem (VSTM) United States $0.233B 0.00
Prima BioMed (IMMP) Australia $0.229B 0.00
AC Immune (ACIU) Switzerland $0.226B 0.00
23andMe Holding (ME) United States $0.222B 0.00
2seventy Bio (TSVT) United States $0.220B 0.00
Coherus BioSciences (CHRS) United States $0.219B 0.00
UniQure (QURE) Netherlands $0.217B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Sutro Biopharma (STRO) United States $0.214B 0.00
Design Therapeutics (DSGN) United States $0.212B 0.00
Opthea (OPT) Australia $0.212B 0.00
Ovid Therapeutics (OVID) United States $0.212B 0.00
Compass Therapeutics (CMPX) United States $0.204B 0.00
G1 Therapeutics (GTHX) United States $0.202B 0.00
Lifecore Biomedical (LFCR) United States $0.201B 0.00
Poseida Therapeutics (PSTX) United States $0.198B 0.00
INmune Bio (INMB) United States $0.197B 0.00
Adverum Biotechnologies (ADVM) United States $0.195B 0.00
Innate Pharma S.A (IPHA) France $0.194B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.192B 0.00
X4 Pharmaceuticals (XFOR) United States $0.190B 0.00
Candel Therapeutics (CADL) United States $0.189B 0.00
Akoya Biosciences (AKYA) United States $0.189B 0.00
Codexis (CDXS) United States $0.186B 0.00
Cardiff Oncology (CRDF) United States $0.178B 0.00
Elevation Oncology (ELEV) United States $0.177B 0.00
Trevi Therapeutics (TRVI) United States $0.175B 0.00
Agenus (AGEN) United States $0.174B 0.00
Alimera Sciences (ALIM) United States $0.173B 0.00
GENFIT S.A (GNFT) France $0.172B 0.00
Adocia (ADOCY) France $0.169B 0.00
Kodiak Sciences (KOD) United States $0.167B 0.00
Inventiva S.A (IVA) France $0.166B 0.00
Compugen (CGEN) Israel $0.165B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.159B 0.00
Greenwich LifeSciences (GLSI) United States $0.159B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.159B 0.00
Skye Bioscience (SKYE) United States $0.159B 0.00
ScPharmaceuticals (SCPH) United States $0.157B 0.00
Zura Bio (ZURA) United States $0.156B 0.00
CervoMed (CRVO) United States $0.154B 0.00
BioStem Technologies (BSEM) $0.153B 0.00
Gossamer Bio (GOSS) United States $0.152B 0.00
Annovis Bio (ANVS) United States $0.150B 0.00
Adicet Bio (ACET) United States $0.149B 0.00
I-Mab (IMAB) China $0.146B 0.00
Scilex Holding (SCLX) United States $0.143B 0.00
Molecular Partners AG (MOLN) Switzerland $0.141B 0.00
Cellectis S.A (CLLS) France $0.138B 0.00
Syros Pharmaceuticals (SYRS) United States $0.136B 0.00
DBV Technologies S.A (DBVT) France $0.133B 0.00
Omega Therapeutics (OMGA) United States $0.130B 0.00
VistaGen Therapeutics (VTGN) United States $0.127B 0.00
Sagimet Biosciences (SGMT) United States $0.125B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
PDS Biotechnology (PDSB) United States $0.120B 0.00
Repare Therapeutics (RPTX) Canada $0.117B 0.00
Vor Biopharma (VOR) $0.116B 0.00
Nuvectis Pharma (NVCT) United States $0.116B 0.00
Immunic (IMUX) United States $0.114B 0.00
Seer (SEER) United States $0.113B 0.00
Cartesian Therapeutics (RNAC) United States $0.113B 0.00
Seres Therapeutics (MCRB) United States $0.112B 0.00
CytomX Therapeutics (CTMX) United States $0.108B 0.00
ATyr Pharma (LIFE) United States $0.108B 0.00
TELA Bio (TELA) United States $0.108B 0.00
BioAtla (BCAB) United States $0.108B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
Sangamo Therapeutics (SGMO) United States $0.104B 0.00
Rezolute (RZLT) United States $0.104B 0.00
Adagene (ADAG) China $0.104B 0.00
Emergent Biosolutions (EBS) United States $0.102B 0.00
BioHarvest Sciences (CNVCF) Canada $0.102B 0.00
Bluebird Bio (BLUE) United States $0.100B 0.00
Vigil Neuroscience (VIGL) United States $0.097B 0.00
BioXcel Therapeutics (BTAI) United States $0.097B 0.00
DiaMedica Therapeutics (DMAC) United States $0.096B 0.00
IO Biotech (IOBT) Denmark $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.095B 0.00
Clearside Biomedical (CLSD) United States $0.094B 0.00
Elicio Therapeutics (ELTX) United States $0.093B 0.00
Q32 Bio (QTTB) United States $0.092B 0.00
Allakos (ALLK) United States $0.089B 0.00
Genelux (GNLX) United States $0.089B 0.00
BeyondSpring (BYSI) United States $0.088B 0.00
Abeona Therapeutics (ABEO) United States $0.087B 0.00
Curis (CRIS) United States $0.086B 0.00
Galena Biopharma (SLS) United States $0.086B 0.00
Aileron Therapeutics (ALRN) United States $0.085B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.084B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
InflaRx (IFRX) Germany $0.082B 0.00
Oncolytics Biotech (ONCY) Canada $0.081B 0.00
Leap Therapeutics (LPTX) United States $0.081B 0.00
Eton Pharmaceuticals (ETON) United States $0.080B 0.00
HOOKIPA Pharma (HOOK) United States $0.080B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.078B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.86
Cognition Therapeutics (CGTX) United States $0.075B 0.00
Passage Bio (PASG) United States $0.075B 0.00
Gritstone Bio (GRTS) United States $0.075B 0.00
Connect Biopharma Holdings (CNTB) United States $0.075B 0.00
Affimed (AFMD) Germany $0.074B 0.00
YS Biopharma (YS) China $0.074B 0.00
Athira Pharma (ATHA) United States $0.074B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.073B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.072B 0.00
Elutia (ELUT) United States $0.070B 0.00
Landos Biopharma (LABP) United States $0.070B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.070B 0.00
Alpha Teknova (TKNO) United States $0.069B 0.00
Cue Biopharma (CUE) United States $0.069B 0.00
AN2 Therapeutics (ANTX) United States $0.068B 0.00
Instil Bio (TIL) United States $0.068B 0.00
Precision BioSciences (DTIL) United States $0.067B 0.00
Turnstone Biologics (TSBX) United States $0.067B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Equillium (EQ) United States $0.064B 0.00
Ikena Oncology (IKNA) United States $0.063B 0.00
Rallybio (RLYB) United States $0.062B 0.00
Aligos Therapeutics (ALGS) United States $0.062B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.061B 0.00
Celularity (CELU) United States $0.059B 0.00
Cidara Therapeutics (CDTX) United States $0.059B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
Lantern Pharma (LTRN) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Kezar Life Sciences (KZR) United States $0.058B 0.00
CalciMedica (CALC) United States $0.057B 0.00
LENZ Therapeutics (LENZ) United States $0.056B 0.00
Immix Biopharma (IMMX) United States $0.055B 0.00
HCW Biologics (HCWB) United States $0.055B 0.00
Enzo Biochem (ENZ) United States $0.055B 0.00
Intensity Therapeutics (INTS) United States $0.054B 0.00
AVROBIO (AVRO) United States $0.053B 0.00
Genenta Science S.p.A (GNTA) Italy $0.053B 0.00
Checkpoint Therapeutics (CKPT) United States $0.051B 0.00
ARCA Biopharma (ABIO) United States $0.050B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.050B 0.00
Prenetics Global (PRE) Cayman Islands $0.045B 0.00
NKGen Biotech (NKGN) United States $0.045B 0.00
Quince Therapeutics (QNCX) United States $0.045B 0.00
Clene (CLNN) United States $0.045B 0.00
Bolt Biotherapeutics (BOLT) United States $0.044B 0.00
Dyadic (DYAI) United States $0.044B 0.00
Ocean Biomedical (OCEA) United States $0.043B 0.00
Immuneering (IMRX) United States $0.042B 0.00
Beyond Air (XAIR) United States $0.042B 0.00
Apollomics (APLM) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.042B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Aadi Bioscience (AADI) United States $0.041B 0.00
Carmell (CTCX) United States $0.040B 0.00
Cara Therapeutics (CARA) United States $0.038B 0.00
Ocuphire Pharma (OCUP) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Cyclo Therapeutics (CYTH) United States $0.037B 0.00
SAB Biotherapeutics (SABS) United States $0.037B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
NextCure (NXTC) United States $0.036B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Eyenovia (EYEN) United States $0.034B 0.00
IN8bio (INAB) United States $0.033B 0.00
Fortress Biotech (FBIO) United States $0.033B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Theratechnologies (THTX) Canada $0.031B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
BioAffinity Technologies (BIAF) United States $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
Pluri (PLUR) Israel $0.025B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Lumos Pharma (LUMO) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Synlogic (SYBX) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.018B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
KALA BIO (KALA) United States $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
ABVC BioPharma (ABVC) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.016B 0.00
Vaxxinity (VAXX) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Semper Paratus Acquisition (TVGN) United States $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Eterna Therapeutics (ERNA) United States $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
Trevena (TRVN) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Kineta (KA) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Kintara Therapeutics (KTRA) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.30
Artelo Biosciences (ARTL) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Seelos Therapeutics (SEEL) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Biophytis SA (BPTS) France $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Sunshine Biopharma (SBFM) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00